Foundation News

NEW YORK, NY – The Crohn’s & Colitis Foundation announced today that it is presenting its Uniting to Care & Cure Awards to 16 healthcare providers from across the country in recognition of their work to help find cures for inflammatory bowel disease (IBD) and improve the quality of life o

NEW YORK, NY – The Crohn’s & Colitis Foundation (the Foundation) has named Dr. David T.

New York, NY – For Crohn’s disease patients with mild-to-moderate symptoms, a Mediterranean style diet and the Specific Carbohydrate Diet™appear to improve symptoms and quality of life, according to a new study published

Check out our May 2021 Chapter Newsletter

The Crohn’s & Colitis Foundation announced today that it has received a $3.3 million grant from The Leona M. and Harry B. Helmsley Charitable Trust to improve the urgent care management of Crohn’s disease through IBD Qorus®, the Foundation’s flagship quality of care program.

Progenity, Inc., a biotechnology company with an established track record of success developing and commercializing molecular testing products, announced today that it has received funding from the Crohn’s & Colitis Foundation’s IBD Ventures program to further develop Progenity’s first-in-class oral Drug Delivery System (DDS) for delivery of targeted therapeutics for inflammatory bowel disease (IBD).

<-->

We are excited to announce the2021 Rising Healthcare Leader in IBD- Dr. Sarah Flier!